|
IMMX Immix Biopharma Inc 1873835 |
| Income Statement |
|
Net Income
|
form10-q
|
-7,149,395 |
| Balance Sheet |
|
Current Assets
|
22,755,505 |
|
Assets
|
25,141,552 |
|
Current Liabilities
|
6,564,501 |
|
Liabilities
|
7,590,841 |
|
Equity
|
17,550,711 |
|
Shares Out
|
27,450,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-13,118,904 |
|
Investing Cash Flow
|
-670,529 |
| Market Analysis |
Market Cap
|
50,783,370 |
|
Price
|
2.04 |
|
BVPS
|
0.64 |
|
PB
|
3.10 |
|
EPS
|
-0.84 |
|
PS
|
287.52 |
|
FCF
|
-13,789,433 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IMMX documents filed with the SEC.
IMMX Filings
Clear
